Isohumulones modulate blood lipid status through the activation of PPARα

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1736, Issue 1, 2005, Pages 51-60

  Shimura, Masako ^a   Hasumi, Akiko ^a   Minato, Toshiko ^a   Hosono, Mayu ^a   Miura, Yutaka ^a   Mizutani, Satoru ^a   Kondo, Keiji ^a   Oikawa, Shinichi ^b   Yoshida, Aruto ^a  

^a KIRIN BREWERY CO LTD   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Atherosclerosis; Beer; Fatty acid oxidation; Hop; Isohumulone; Liver; Microarray; Nutrigenomics; PPAR ; Triglyceride

Indexed keywords

FENOFIBRATE; HUMULUS LUPULUS EXTRACT; ISOADHUMULONE; ISOCOHUMULONE; ISOHUMULONE; ISOMERIZED HOP EXTRACT; KETONE DERIVATIVE; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; FATTY ACID BLOOD LEVEL; FATTY ACID OMEGA OXIDATION; FATTY ACID OXIDATION; FEMALE; GENDER; GENE EXPRESSION; ISOMERIZATION; LIPID BLOOD LEVEL; LIPID METABOLISM; LIVER MICROSOME; LIVER WEIGHT; MALE; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; UNINDEXED SEQUENCE; UPREGULATION;

3-HYDROXYACYL COA DEHYDROGENASES; ACETYL-COA C-ACYLTRANSFERASE; ANIMALS; CARBON-CARBON DOUBLE BOND ISOMERASES; CYCLOPENTANES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENOYL-COA HYDRATASE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIPIDS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; PPAR ALPHA; RACEMASES AND EPIMERASES; SEX FACTORS;

HUMULUS LUPULUS;

EID: 23944508265     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2005.06.008     Document Type: Article

References (42)

1. C. Duval, G. Chinetti, F. Trottein, J.C. Fruchart, and B. Staels The role of PPARs in atherosclerosis Trends Mol. Med. 8 2002 422 430
2. B. Staels, J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf, and J.C. Fruchart Mechanism of action of fibrates on lipid and lipoprotein metabolism Circulation 98 1998 2088 2093
3. S. Kersten, B. Desvergne, and W. Wahli Roles of PPARs in health and disease Nature 405 2000 421 424
4. J.K. Reddy, and T. Hashimoto Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system Annu. Rev. Nutr. 21 2001 193 230
5. S.A. Kliewer, H.E. Xu, M.H. Lambert, and T.M. Willson Peroxisome proliferator-activated receptors: from genes to physiology Recent Prog. Horm. Res. 56 2001 239 263
6. P. Ferre The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity Diabetes 53 Suppl. 1 2004 S43 S50
7. D.R. Guay Update on fenofibrate Cardiovasc. Drug Rev. 20 2002 281 302
8. M. Guerre-Millo, P. Gervois, E. Raspe, L. Madsen, P. Poulain, B. Derudas, J.M. Herbert, D.A. Winegar, T.M. Willson, J.C. Fruchart, R.K. Berge, and B. Staels Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity J. Biol. Chem. 275 2000 16638 16642
9. C.J. Chou, M. Haluzik, C. Gregory, K.R. Dietz, C. Vinson, O. Gavrilova, and M.L. Reitman WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha ) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice J. Biol. Chem. 277 2002 24484 24489
10. H. Kim, M. Haluzik, Z. Asghar, D. Yau, J.W. Joseph, A.M. Fernandez, M.L. Reitman, S. Yakar, B. Stannard, L. Heron-Milhavet, M.B. Wheeler, and D. LeRoith Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis Diabetes 52 2003 1770 1778
11. J. Minamikawa, S. Tanaka, M. Yamauchi, D. Inoue, and H. Koshiyama Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes J. Clin. Endocrinol. Metab. 83 1998 1818 1820
12. H. Koshiyama, D. Shimono, N. Kuwamura, J. Minamikawa, and Y. Nakamura Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes J. Clin. Endocrinol. Metab. 86 2001 3452 3456
13. H. Yajima, E. Ikeshima, M. Shiraki, T. Kanaya, D. Fujiwara, H. Odai, N. Tsuboyama-Kasaoka, O. Ezaki, S. Oikawa, and K. Kondo Isohumulones, bitter acids derived from hops, activate both peroxisome proliferator-activated Receptor {alpha} and {gamma} and reduce insulin resistance J. Biol. Chem. 279 2004 33456 33462
14. Y. Miura, M. Hosono, C. Oyamada, S. Oikawa, and K. Kondo Dietary isohumulones, the bitter components of beer, raise plasama HDL cholesterol levels and reduce liver cholesterol and triglyceride contents similar to PPAR {alpha} activations in C57BL/6 mice Br. J. Nutr. 93 2005 559 567
15. S. Rozen, and H. Skaletsky Primer3 on the WWW for general users and for biologist programmers Methods Mol. Biol. 132 2000 365 386
16. H. Ogata, S. Goto, K. Sato, W. Fujibuchi, H. Bono, and M. Kanehisa KEGG: Kyoto encyclopedia of genes and genomes Nucleic Acids Res. 27 1999 29 34
17. J. Laborda 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO Nucleic Acids Res. 19 1991 3998
18. M. Cherkaoui-Malki, K. Meyer, W.Q. Cao, N. Latruffe, A.V. Yeldandi, M.S. Rao, C.A. Bradfield, and J.K. Reddy Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis Gene Expr. 9 2001 291 304
19. K. Yamazaki, J. Kuromitsu, and I. Tanaka Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator-activated receptor alpha agonists Biochem. Biophys. Res. Commun. 290 2002 1114 1122
20. K.S. Frederiksen, E.M. Wulff, P. Sauerberg, J.P. Mogensen, L. Jeppesen, and J. Fleckner Prediction of PPAR-alpha ligand-mediated physiological changes using gene expression profiles J. Lipid Res. 45 2004 592 601
21. K. Schoonjans, B. Staels, and J. Auwerx The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation Biochim. Biophys. Acta 1302 1996 93 109
22. D.R. Bell, N.J. Plant, C.G. Rider, L. Na, S. Brown, I. Ateitalla, S.K. Acharya, M.H. Davies, E. Elias, and N.A. Jenkins Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4A cDNAs Biochem. J. 294 Pt 1 1993 173 180
23. Y.M. Heng, C.S. Kuo, P.S. Jones, R. Savory, R.M. Schulz, S.R. Tomlinson, T.J. Gray, and D.R. Bell A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans Biochem. J. 325 Pt 3 1997 741 749
24. C.Y. Fan, J. Pan, R. Chu, D. Lee, K.D. Kluckman, N. Usuda, I. Singh, A.V. Yeldandi, M.S. Rao, N. Maeda, and J.K. Reddy Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene J. Biol. Chem. 271 1996 24698 24710
25. B.V. Geisbrecht, D. Zhang, H. Schulz, and S.J. Gould Characterization of PECI, a novel monofunctional Delta(3), Delta(2)-enoyl-CoA isomerase of mammalian peroxisomes J. Biol. Chem. 274 1999 21797 21803
26. C. Qi, Y. Zhu, J. Pan, N. Usuda, N. Maeda, A.V. Yeldandi, M.S. Rao, T. Hashimoto, and J.K. Reddy Absence of spontaneous peroxisome proliferation in enoyl-CoA Hydratase/l-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism J. Biol. Chem. 274 1999 15775 15780
27. G. Chevillard, M.C. Clemencet, P. Etienne, P. Martin, T. Pineau, N. Latruffe, and V. Nicolas-Frances Molecular cloning, gene structure and expression profile of two mouse peroxisomal 3-ketoacyl-CoA thiolase genes BMC Biochem. 5 2004 3
28. B.D. Gelb Genomic structure of and a cardiac promoter for the mouse carnitine palmitoyltransferase II gene Genomics 18 1993 651 655
29. S. Brunner, K. Kramar, D.T. Denhardt, and R. Hofbauer Cloning and characterization of murine carnitine acetyltransferase: evidence for a requirement during cell cycle progression Biochem. J. 322 Pt 2 1997 403 410
30. W. Stoffel, M. Duker, and K. Hofmann Molecular cloning and gene organization of the mouse mitochondrial 3,2-trans-enoyl-CoA isomerase FEBS Lett. 333 1993 119 122
31. R.A. Coleman, T.M. Lewin, C.G. Van Horn, and M.R. Gonzalez-Baro Do long-chain acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways? J. Nutr. 132 2002 2123 2126
32. S.S. Lee, T. Pineau, J. Drago, E.J. Lee, J.W. Owens, D.L. Kroetz, P.M. Fernandez-Salguero, H. Westphal, and F.J. Gonzalez Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators Mol. Cell. Biol. 15 1995 3012 3022
33. T.E. Akiyama, C.J. Nicol, C. Fievet, B. Staels, J.M. Ward, J. Auwerx, S.S. Lee, F.J. Gonzalez, and J.M. Peters Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines J. Biol. Chem. 276 2001 39088 39093
34. K. Motojima Differential effects of PPARalpha activators on induction of ectopic expression of tissue-specific fatty acid binding protein genes in the mouse liver Int. J. Biochem. Cell Biol. 32 2000 1085 1092
35. S.S. Sundseth, and D.J. Waxman Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone J. Biol. Chem. 267 1992 3915 3921
36. H. Duez, B. Lefebvre, P. Poulain, I. Pineda Torra, F. Percevault, G. Luc, J.M. Peters, F.J. Gonzalez, R. Gineste, S. Helleboid, J.C. Fruchart, C. Fievet, P. Lefebvre, and B. Staels Regulation of human ApoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor {alpha} modulation Arterioscler. Thromb. Vasc. Biol. 25 2005 585 591
37. M. Yoon, S. Jeong, C.J. Nicol, H. Lee, M. Han, J.J. Kim, Y.J. Seo, C. Ryu, and G.T. Oh Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism Exp. Mol. Med. 34 2002 481 488
38. H. Yajima, T. Noguchi, E. Ikeshima, M. Shiraki, T. Kanaya, N. Tsuboyama-Kasaoka, O. Ezaki, S. Oikawa, K. Kondo, Prevention of diet-induced obesity by dietary isomerized hop extract containing isohumulones, in rodents, Int. J. Obes. Relat. Metab. Disord. (in press).
39. A. Galli, J. Pinaire, M. Fischer, R. Dorris, and D.W. Crabb The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver J. Biol. Chem. 276 2001 68 75
40. M. Fischer, M. You, M. Matsumoto, and D.W. Crabb Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice J. Biol. Chem. 278 2003 27997 28004
41. M. Tsutsumi, and S. Takase Effect of fenofibrate on fatty liver in rats treated with alcohol Alcohol., Clin. Exp. Res. 25 2001 75S 79S
42. T. Nakajima, Y. Kamijo, N. Tanaka, E. Sugiyama, E. Tanaka, K. Kiyosawa, Y. Fukushima, J.M. Peters, F.J. Gonzalez, and T. Aoyama Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage Hepatology 40 2004 972